These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20123526)

  • 1. [External validation of the University of Los Angeles Integrated Staging System (UISS) in localized renal cell carcinoma: single center study].
    Onea C; Mouracade P; Roman H; Wagner B; Saussine C; Jacqmin D; Lang H
    Prog Urol; 2010 Jan; 20(1):35-9. PubMed ID: 20123526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study.
    Patard JJ; Kim HL; Lam JS; Dorey FJ; Pantuck AJ; Zisman A; Ficarra V; Han KR; Cindolo L; De La Taille A; Tostain J; Artibani W; Dinney CP; Wood CG; Swanson DA; Abbou CC; Lobel B; Mulders PF; Chopin DK; Figlin RA; Belldegrun AS
    J Clin Oncol; 2004 Aug; 22(16):3316-22. PubMed ID: 15310775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 'Stage, Size, Grade and Necrosis' score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma.
    Ficarra V; Novara G; Galfano A; Brunelli M; Cavalleri S; Martignoni G; Artibani W
    BJU Int; 2009 Jan; 103(2):165-70. PubMed ID: 18782313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
    Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
    Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
    Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy.
    Cindolo L; Chiodini P; Gallo C; Ficarra V; Schips L; Tostain J; de La Taille A; Artibani W; Patard JJ
    Cancer; 2008 Jul; 113(1):65-71. PubMed ID: 18473356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies.
    Belldegrun AS; Klatte T; Shuch B; LaRochelle JC; Miller DC; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Dekernion JB; Pantuck AJ
    Cancer; 2008 Nov; 113(9):2457-63. PubMed ID: 18823034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.
    Liu Z; Lv J; Ding K; Fu Q; Cao Q; Wang F
    Int J Urol; 2009 Mar; 16(3):268-73. PubMed ID: 19087209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosticfactors in patients with renal cell carcinoma: is TNM (1997) staging relevant in Indian subpopulation?
    Srivastava A; Mandhani A; Kapoor R; Jain M; Dubey D; Srivastava A; Raghavendra M; Kumar A
    Indian J Cancer; 2004; 41(3):99-103. PubMed ID: 15472406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence.
    Eggener SE; Yossepowitch O; Pettus JA; Snyder ME; Motzer RJ; Russo P
    J Clin Oncol; 2006 Jul; 24(19):3101-6. PubMed ID: 16809736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
    Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
    Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved prognostication of renal cell carcinoma using an integrated staging system.
    Zisman A; Pantuck AJ; Dorey F; Said JW; Shvarts O; Quintana D; Gitlitz BJ; deKernion JB; Figlin RA; Belldegrun AS
    J Clin Oncol; 2001 Mar; 19(6):1649-57. PubMed ID: 11250993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma.
    Verhoest G; Avakian R; Bensalah K; Thuret R; Ficarra V; Artibani W; Tostain J; Guille F; Cindolo L; De La Taille A; Abbou CC; Salomon L; Rioux-Leclercq N; Patard JJ
    J Urol; 2009 Sep; 182(3):854-9. PubMed ID: 19616244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using protein expressions to predict survival in clear cell renal carcinoma.
    Kim HL; Seligson D; Liu X; Janzen N; Bui MH; Yu H; Shi T; Figlin RA; Horvath S; Belldegrun AS
    Clin Cancer Res; 2004 Aug; 10(16):5464-71. PubMed ID: 15328185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.
    Lang H; Lindner V; de Fromont M; Molinié V; Letourneux H; Meyer N; Martin M; Jacqmin D
    Cancer; 2005 Feb; 103(3):625-9. PubMed ID: 15611969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?
    Ficarra V; Novara G; Galfano A; Novella G; Schiavone D; Artibani W
    Urology; 2004 Jun; 63(6):1050-4. PubMed ID: 15183948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
    Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
    Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
    Klatte T; Seligson DB; LaRochelle J; Shuch B; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Pantuck AJ; Belldegrun AS
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):894-900. PubMed ID: 19240241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated staging systems for conventional renal cell carcinoma: a comparison of two prognostic models.
    Martella O; Galatioto GP; Necozione S; Pomante R; Vicentini C
    Arch Ital Urol Androl; 2011 Sep; 83(3):121-7. PubMed ID: 22184835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.